Revolution Vibe vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Revolution Vibe

by GE HealthCare

Tempus ECG-AF

by Tempus AI, Inc.

AI Verdict

Revolution Vibe is an AI-powered CT imaging system designed for detailed cardiac anatomical and functional assessment through high-quality scans. In contrast, Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECGs to predict the risk of future atrial fibrillation. While both are cardiology AI tools, they serve distinct purposes: one for advanced diagnostic imaging and the other for predictive risk stratification based on ECG data.

Choose Revolution Vibe if…

Choose Revolution Vibe if your facility requires a cutting-edge CT imaging system for comprehensive and highly detailed cardiac anatomical assessment. This tool is ideal for advanced coronary CT angiography (CCTA), complex cardiac cases, and situations demanding low-dose, high-resolution imaging for precise diagnosis and treatment planning, even in challenging patients with arrhythmias or breath-holding difficulties.

View Revolution Vibe →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your clinical practice aims to proactively identify older patients (65+) at an increased risk of developing new-onset atrial fibrillation within the next 12 months. This AI-based software solution is best suited for integrating into existing cardiology workflows to analyze standard 12-lead ECGs, supporting earlier risk stratification and guiding targeted follow-up for at-risk individuals without a prior AF diagnosis or specific cardiac devices.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Revolution Vibe	Tempus ECG-AF
Pricing	Contact vendor for quote	Contact vendor
Deployment	On-premise (physical medical device installation)	Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Revolution Vibe	Tempus ECG-AF
Product Name	Revolution Vibe	Tempus ECG-AF
Company	GE HealthCare	Tempus AI, Inc.
Primary Function	AI-powered CT system optimized for advanced cardiac imaging, including Coronary CT Angiography (CCTA), delivering high-quality, low-dose images with streamlined workflows.	FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Target Patient Population/Use Case	Patients requiring advanced cardiac imaging, including CCTA, for full-heart clarity at low dose.	Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to identify increased risk of developing AF within 12 months.
Key Technology/Methodology	AI-powered CT system with features like Unlimited One-Beat Cardiac imaging, AI-powered Effortless Cardiac Workflow, ECG-less Cardiac CT, TrueFidelity DL, SnapShot Freeze 2.	AI-based algorithm for 12-lead ECG analysis, trained on over 1.5 million ECGs.

Videos

Demos, reviews, and walkthroughs featuring Revolution Vibe and Tempus ECG-AF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical function of each tool?

GE HealthCare's Revolution Vibe is an AI-powered CT system designed for advanced cardiac imaging, including Coronary CT Angiography (CCTA), to deliver high-quality, low-dose images. Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.

For which patient populations are these tools specifically intended?

Revolution Vibe is optimized for advanced cardiac imaging for a broad range of patients, including those with challenging conditions like irregular heart rhythms or heavily calcified arteries. Tempus ECG-AF is intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to assess their risk of developing AF within 12 months.

Are there specific reimbursement details available for either tool?

For Tempus ECG-AF, CMS reimbursement is available with CPT codes 0764T and 0765T, assigned to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025. Revolution Vibe's pricing is not publicly available and is typically negotiated directly with GE HealthCare.

What are the key features that enhance image quality or analytical capabilities?

Revolution Vibe offers Unlimited One-Beat Cardiac imaging for full-heart clarity at low dose, TrueFidelity DL, and SnapShot Freeze 2 for motion-free, high-quality image reconstruction. Tempus ECG-AF's key feature is its AI-based algorithm for 12-lead ECG analysis, trained on over 1.5 million ECGs, to detect signs associated with new onset Atrial Fibrillation.

How do these tools impact clinical workflow and efficiency?

Revolution Vibe features an AI-powered Effortless Cardiac Workflow for automated protocol selection and patient positioning, and ECG-less Cardiac CT for simplified patient preparation. Tempus ECG-AF supports earlier identification and follow-up for patients at risk of AF, and is designed to work with existing ECG platforms and EHRs.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform